Medicine without Meds

Dean Ho (SINGAPORE) is the Provost's Chair Professor, the Director of the Institute for Digital Medicine and the N.1 Institute for Health, and the Head of the Department of Biomedical Engineering at the National University of Singapore. Yoann Sapanel (SINGAPORE) is the Head of Health Innovation at the Institute for Digital Medicine at the National University of Singapore. Agata Blasiak (SINGAPORE) is the Head of Digital Health Innovation at the Institute for Digital Medicine and the N.1 Institute for Health at the National University of Singapore.

Foreword by D.A. Wallach: It is time for healthcare to embrace patients Preface Introduction: The Context Part I: What Are Digital Therapeutics? 1. Digital Health Solutions Versus Digital Therapeutics Part II: The Right Tool for The Right Problem 1. Addressing Unmet Stakeholder Needs 2. Addressing Unmet Clinical Needs 3. Ensuring Business Viability Early 4. Test, Learn, and Pivot Part III: From Pilot to Production 5. Data Sourcing and Management 6. Gathering Evidence: Novel Approaches to Clinical Validation 7. Factors That Influence the Implementation of New Technologies 8. Recommendations for DTx Implementation 9. Supporting Adoption of DTx Part IV: Paths to Commercialization 10. Channel Partnerships: The Ultimate Commercialization Strategy 11. The Price is Right:: Value in The Eye of The Beholder Conclusion by Dr Eddie Martucci: The Future of DTx Appendix Bibliography Acknowledgments Index

This book shares useful resources, discusses insightful case studies (both successful and unsuccessful), and provides guidelines at various technology and business development stages. The case studies and key takeaways are particularly instrumental and enjoyable to read. The international coverage of the topic is another highlight of the book. I consider the book highly original, and it represents a substantial contribution to the digital therapeutic space. It should be a must-read. -Pak Kin Wong, PhD, The Pennsylvania State University